Objective Genetic and environmental factors play an interactive role in the development of acute lymphoblastic leukemia (ALL) and chronic myelogenous leukemia(CML). Since the demonstration of a major histocompatibility complex (MHC) influence on mouse leukemia in 1964, an HLA association has been considered as a possible genetic risk factor. Despite extensive efforts, however, no strong evidence comparable to the H-2~k influence on mouse leukemia has been shown. We reconsidered the HLA-DRB1 association in patients with acute lymphoblastic leukemia ( ALL ) and .chronic myelogenous leukemia(CML). We hope that these results will be used as a guide for further functional studies and be considered in the ongoing cancer studies.Methods HLA-DRB1 allele in 32 Chinese patients with ALL, 33 with CML and 104 healthy individuals of Fujian native Han Population were identified by polymerase chain reaction - specific sequence primers (PCR-SSP) methods. The data, therefore, can be used to estimate the relative risk for ALL and CML.Results The gene frequency of HLA-DRB1*06 in ALL patient is significantly higher than that in healthy controls (15.63% vs 5.29%, p<0.001). The relative Risk of HLA-DRB1*06 to ALL is 3.84. The gene frequency of HLA-DRB1*09 in CML patient is significantly higher than that in healthy controls (24.24% vs 11.54%, p<0.01). The relative Risk of HLA-DRB1*06 to CML is 3.14.Conclusion The present results suggest positive association of HLA-DRB1*06 with ALL, and HLA-DRB1*09 with CML respectively.HLA-DRB1*O6 and HLA-DRB1*O9 alleles seem to contribute to the genetic susceptibility for patients with ALL and CML respectively.
|